039840.KQ
DIO Corporation
KOE · Healthcare · Medical - Instruments & Supplies · KR
KRW 11,010.00
+0.18%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 174.4B | 164.1B | 119.6B | 155.8B | 131.3B |
| Cost of Revenue | 63.7B | 59.0B | 45.9B | 42.7B | 50.2B |
| Gross Profit | 110.8B | 105.0B | 73.8B | 113.1B | 81.2B |
| Operating Expenses | |||||
| R&D Expense | 3.3B | 4.1B | 5.2B | 3.8B | 3.9B |
| SG&A Expense | 41.8B | 27.1B | 19.2B | 21.3B | 22.5B |
| General & Admin Expense | 5.7B | 7.6B | 7.0B | 8.0B | 8.0B |
| Selling & Marketing Expense | 21.3B | 19.6B | 12.2B | 13.2B | 14.5B |
| Other Expenses | 52.8B | 63.6B | 90.1B | 67.1B | (2.3B) |
| Total Operating Expenses | 97.5B | 94.9B | 114.5B | 92.2B | 87.7B |
| Cost and Expenses | 161.2B | 154.0B | 160.4B | 134.9B | 137.8B |
| Operating Income (EBIT) | 13.3B | 10.2B | (40.7B) | 20.9B | (6.5B) |
| Non-Operating | |||||
| Interest Income | 1.0B | 1.3B | 1.3B | 257.3M | 149.3M |
| Interest Expense | 4.2B | 4.2B | 5.8B | 7.7B | 5.0B |
| Net Interest Income | (3.2B) | (2.9B) | (4.5B) | (7.5B) | (4.9B) |
| Other Non-Op Income/Expense | 10.9B | (16.8B) | (9.7B) | (10.5B) | (14.6B) |
| Non-Operating Income (excl Interest) | (935.7M) | 12.5B | 3.9B | 2.8B | 9.6B |
| EBT (Pre-Tax Income) | 24.2B | (6.6B) | (50.0B) | 10.4B | (21.0B) |
| Income Tax Expense | 2.1B | (5.2B) | (9.1B) | 7.8B | (968.1M) |
| Bottom Line | |||||
| Net Income | 22.1B | (1.4B) | (41.3B) | 3.3B | (20.5B) |
| Earnings from Cont. Ops | 22.1B | (1.4B) | (41.3B) | 2.6B | (20.1B) |
| Earnings from Discont. Ops | — | — | — | — | 105.2M |
| Bottom Line Net Income | 22.1B | (1.4B) | (41.3B) | 3.3B | (20.5B) |
| Per Share | |||||
| Basic EPS | ₩1,656 | (₩95) | (₩2,865) | ₩227 | (₩1,380) |
| Diluted EPS | ₩1,364 | (₩95) | (₩2,865) | ₩227 | (₩1,380) |
| Revenue Per Share | ₩13,509 | ₩11,414 | ₩8,296 | ₩10,703 | ₩8,858 |
| Shares | |||||
| Basic Shares Outstanding | 12.9M | 14.4M | 14.4M | 14.6M | 14.8M |
| Diluted Shares Outstanding | 16.3M | 14.4M | 14.4M | 14.6M | 14.8M |
| Profitability Metrics | |||||
| EBITDA | 26.9B | 19.6B | (33.4B) | 30.4B | (2.9B) |
| D&A | 9.7B | 9.4B | 11.2B | 12.3B | 13.2B |
| EBIT | 17.1B | 10.2B | (44.7B) | 18.1B | (16.1B) |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026